Synlogic Inc (NASDAQ:SYBX)
| 2.50 Delayed Data As of 3:52pm ET |  0.00 / 0.00%Today’s Change | 1.61 Today|||52-Week Range 16.50 | -78.07% Year-to-Date |
Latest SYBX News | Press Releases
No recent news for Synlogic Inc.
Today’s Trading
| Previous close | 2.50 |
| Today’s open | 2.56 |
| Day’s range | 2.50 - 2.77 |
| Volume | 1,499 |
| Average volume (3 months) | 30,531 |
| Market cap | $18.1M |
Data as of 3:52pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +15.74% |
| Earnings growth (this year) | +93.33% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -32.73% |
| P/E ratio | NM |
| Price/Sales | 46.20 |
| Price/Book | 0.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Inveritech Solutions... | 0.00 | 0.00% |
| LCTXLineage Cell Therape... | +0.00 | +0.26% |
| ---- | ||
| ---- |
Data as of 3:58pm ET, 12/01/2023
Financials
| Next reporting date | March 14, 2024 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$66.1M |
| Net profit margin | -5,605.68% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
